AI Global Healthcare Initiative Logomark

AI Global Healthcare Initiative

Moving to a world of predictive methodologies to protect and advance public health.

Over the past century, healthcare-related industries have amassed large amounts of data that remains untapped.

As global regulators, pharmaceutical and medical device industry members, and users at the point of care (POC) — AIGHI works collaboratively to advance the use and usefulness of AI to improve patient care and quality of life. Our vision is to lead and inspire medical device and pharmaceutical industry members, global regulators, and users at the point of care to collaboratively leverage artificial intelligence to advance patient health, product quality, and process improvement.

Why we’re different

Our mission is to challenge and advance current approaches to patient health, product quality, and process improvement by unleashing the power of AI through collaboration across pharmaceutical and medical device industry members, global regulators, and users at the point of care.

Through the power of AI, we can now make decisions with more robust data and information than ever before. We can identify medical solutions that will improve quality of life, prevent illness, and cure diseases. We can predict failures to increase the assurance of product quality, business efficiency, and global health. We are on the cusp of revolutionizing healthful living for today and tomorrow!

We are also pleased to be support by the

Download 5

FDA/Industry/Users-at-POC Working Teams

Through the Artificial Intelligence Initiative, chartered working teams have been established during the face-to-face setting of the annual Healthcare Products Collaborative AI Summit. Check out the team links on this site to learn more about their work, their deliverables, and also take an opportunity to make a difference in lives around the world by joining us! The teams that are currently formed are as follows, and they’re accepting new members:

AIO

AI in Operations Team

Learn more

GMLP

Good Machine Learning Practices Team

Learn more

AI@POC

AI at the Point of Care Team

Learn more

Interested in joining one of the Healthcare Products Collaborative AI Initiative working teams?

It is expected that you participate in the standing meetings (schedule is determined by each team).

It is expected that you participate in the standing meetings (schedule is determined by each team).

Plan on a time commitment of 5 hours per month, but this may vary.

Explore how you can use AI in your organization starting today and how far it can be taken into the future.

Request to join

The membership fee for 2022 will be WAIVED for everyone as we transition to management of our ai work team programs under AFDO/RAPS. Any member who previously paid a 2022 membership fee, will receive a free membership for 2023.

The AFDO/RAPS Healthcare Products Collaborative is a joint venture established in 2022 between the Association of Food and Drug Officials and the Regulatory Affairs Professionals Society. Learn more.

Newsletter

Stay in the know about upcoming events and breaking news from the collaborative.

Subscribe

ContACT

Have questions about our events or how to get involved with one of our committees or workgroups?

Get in touch

© 2024 AFDO/RAPS Healthcare Products Collaborative